Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 30 July 2016

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Polypectomy rate as a surrogate for adenoma detection rate

Polypectomy rate as a surrogate for adenoma detection rate varies by colon segment, gender, and endoscopist, reports the latest issue of the Clinical Gastroenterology & Hepatology.

News image

The adenoma detection rate is an important measure of the quality of colonoscopy.

It is associated with interval colorectal cancer and varies among sexes and locations.

Recommended indicators of competence for colonoscopy include minimal adenoma detection rate >25% for average-risk men and >15% for women.

These adenoma detection rates are rigorous, so polypectomy detection rate has been suggested as a surrogate.

Colonoscopy is less effective in the proximal colon, where interval cancers are more likely to occur.

Dr Madhusudhan Sanaka and colleagues compared adenoma detection rates and polypectomy detection rates in different segments of colon and between sexes.

The mean overall polypectomy detection rate was 42%
Clinical Gastroenterology & Hepatology

The research team performed a cross-sectional review of findings from 2167 screening colonoscopies performed by 65 endoscopists on average-risk outpatients at the Cleveland Clinic, 20082009.

The team reviewed colonoscopy and pathology reports of randomly selected procedures.

The researchers calculated polypectomy detection rates, adenoma detection rates, and correlation between polypectomy and adenoma detection rate for each colon segment and sex.

The team found that the mean overall polypectomy detection rate was 42%, and adenoma detection rate was 25%.

The team noted that the correlation between overall adenoma detection rate and polypectomy detection rate was stron.

Polypectomy detection rate of 40% in men and 30% in women correlated with the established minimum benchmark adenoma detection rates of 25% and 15% for men and women, respectively.

Polypectomy detection rate was more strongly correlated with adenoma detection rate in the proximal colon than the distal colon.

The researcher's correlation was stronger in men than in women, as well as in the entire colon, the proximal colon, and the distal colon.

The advanced adenoma detection rate was 4% and did not correlate with polypectomy detection rate.

Dr Sanaka's team concludes, "On the basis of a review of findings from screening colonoscopies, overall polypectomy detection rate correlates with adenoma detection rate for the entire colon, but polypectomy detection rate and adenoma detection rate correlate most strongly for the proximal colon, where many adenomas can be missed and interval cancers develop."

"The correlation between polypectomy detection rate and adenoma detection rate is weaker for women than men and for distal colon."

"If polypectomy detection rate is used as a surrogate for adenoma detection rate, colon location and patient sex should be considered."

Clin Gastroenterol Hepatol 2014: 12(7): 11371142
30 June 2014

Go to top of page Email this page Email this page to a colleague

 29 July 2016 
Susceptibility loci for gallstone disease
 29 July 2016 
H. pylori clarithromycin resistance in the USA
 29 July 2016 
Tool to diagnose Helicobacter-negative gastritis
 28 July 2016 
HCV eradication in cirrhotic patients
 28 July 2016 
Hep B screening and immunosuppressive therapy
 28 July 2016 
Pancreatitis after ERCP
 27 July 2016 
Gluten exposure in patients with celiac disease
 27 July 2016 
Bleeding GI recurrence with aspirin use
 27 July 2016 
IBD during pregnancy
 26 July 2016 
Gut microbiota and IBD
 26 July 2016 
Neighborhood variation in the use of laparoscopy for colon cancer
 26 July 2016 
Post-infectious IBS after C. diff
 25 July 2016 
Antibiotic prophylaxis for open colectomies
 25 July 2016 
Steroids in eosinophilic esophagitis
 25 July 2016 
Prevention of post-ERCP pancreatitis
 22 July 2016 
Upper GI lesions at primary diagnosis in IBD
 22 July 2016 
Duodenal villous atrophy and celiac disease
 22 July 2016 
Fecal calprotectin and IBD
 21 July 2016 
Radiofrequency ablation in Barrett's
 21 July 2016 
HCV eradication and inflammation in cirrhotic patients
 21 July 2016 
Surveillance of Barrett's
 20 July 2016 
Nonselective β-blockers and survival in cirrhosis
 20 July 2016 
Adolescent body mass index and and colorectal cancer risk
 20 July 2016 
Genetic biomarkers and IBD treatment response
 19 July 2016 
Prevention of chemotherapy-induced nausea and vomiting
 19 July 2016 
Screening diabetic patients for NAFLD
 19 July 2016 
Longterm clinical follow-up of living liver donors
 18 July 2016 
Rectal neuroendocrine tumors
 18 July 2016 
Liver cancer prediction scores in Hep B
 18 July 2016 
Liver stiffness measurement in chronic liver disease
 15 July 2016 
Patient reported outcomes in celiac disease
 15 July 2016 
Tonsillectomy and IBD risk
 15 July 2016 
Trainee IBD education in the USA
 14 July 2016 
Screening for familial pancreatic cancer
 14 July 2016 
Fecal calprotection for IBD prognosis
 14 July 2016 
Perianal surgery risk in Crohn's
 13 July 2016 
Psychological comorbidity and postinfectious IBS
 13 July 2016 
Lung transplant outcomes in Hep C
 13 July 2016 
Graft selection strategy in living donor liver transplants
 12 July 2016 
Surveillance endoscopy in Barrett's esophagus
 12 July 2016 
Therapy for iron deficiency anemia in IBD
 12 July 2016 
Treatment of pediatric acute liver failure
 11 July 2016 
Transition to adulthood in celiac disease
 11 July 2016 
Disturbed sleep and IBS
 11 July 2016 
Factors that influence access to liver transplant
 08 July 2016 
Mortality and peptic ulcers
 08 July 2016 
Genetic risk score and body mass index
 08 July 2016 
Statins and cirrhosis in Hep B
 07 July 2016 
Predicting food triggers in eosinophilic esophagitis
 07 July 2016 
Extraperitoneal vs transperitoneal colostomy for hernia
 07 July 2016 
Predictors fecal transplant failure in C. diff infection
 06 July 2016 
Therapies for Hep B cure
 06 July 2016 
Hospital volume and liver cancer survival
 06 July 2016 
Adverse events after outpatient colonoscopy
 05 July 2016 
Colorectal surgery and dialysis
 05 July 2016 
Exercise and gastroesophageal reflux
 05 July 2016 
Non-invasive scoring systems for fibrosis in NAFLD
 04 July 2016 
Autoimmunity in eosinophilic esophagitis and families
 04 July 2016 
Rectal cancer surgery checklist
 04 July 2016 
Guidelines on PPI and NSAID prescription

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2016 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us